Surmodics Inc (FRA:SU6)
€ 33.8 0 (0%) Market Cap: 494.12 Mil Enterprise Value: 489.78 Mil PE Ratio: 0 PB Ratio: 4.54 GF Score: 82/100

Surmodics Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 05:30PM GMT
Release Date Price: €18 (+2.86%)
LJ LaPorta
Jefferies - Analyst

Good afternoon, everybody. My name is LJ LaPorta. I'm with Jefferies investment banking. I'd like to introduce to you this afternoon, Gary Maharaj, President and CEO, and Tim Arens, SVP of Finance and CFO, of Surmodics.

Gary Maharaj
Surmodics, Inc. - President & CEO

Thank you. So, just bring your attention to the intrinsic risks and probabilities of our Safe Harbor statement, anything forward-looking as you all know.

So, Surmodics is a -- if you're new to the stock, it's a company that it's worth the effort to understand it because there is some tremendous technologies and products in there, which I hope to be able to share with you here. We were founded in 1979. We're based in Minneapolis, and we have a plant also in Galway, Ireland. Fiscal 2022 revenue was about $100 million. Market capitalization as of March 31 was $320 million.

So, the really big thing to grapple with is we are a small company, but we're almost like a combination of several businesses. These businesses -- they are the two technology

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot